Aerie Pharma (AERI) Misses Q4 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.72), $0.05 worse than the analyst estimate of ($0.67).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c